CAITLIN MCGRATH: Open Payments
NPI 1255774006 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$80 in 2 payments from 2 companies in 2025. Trend: 2023 $79 · 2024 $103 · 2025 $80
Food & beverage: $80
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $65 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Ozempic, SHINGRIX.
Industry payments across IN — which companies pay providers there.
